Aspirin Articles

STOCK MARKET COMMENTARY: EUROPE

4 May 1992

BAYER'S CIPROXIN & UTIs

27 April 1992

TWO NEW LICENSING DEALS FOR ROBERTS

20 April 1992

BAYER JAPAN PROFITS BOOST

13 April 1992

LOWER SALES/PROFIT FOR BAYER ITALY

6 April 1992

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

ASPIRIN HELPS BAYER IN ITALY

6 April 1992

MILES STAFF CUTS

6 April 1992

BAYER DIAGNOSTICS' NEW INSTRUMENT

6 April 1992

MILES STAFF CUTS

6 April 1992

BAYER DIAGNOSTICS' NEW INSTRUMENT

6 April 1992

ASPIRIN HELPS BAYER IN ITALY

6 April 1992

EURO DRUGMAKERS STOCK "UNDERVALUED"

6 April 1992

LOWER SALES/PROFIT FOR BAYER ITALY

6 April 1992

SELF-MEDICATION IN EUROPE IN THE 1990s

23 March 1992

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

TEN YEARS OF ACE INHIBITION

23 March 1992

FROM A RESEARCH-LED TO A MARKET-DRIVEN FIRM

23 March 1992

GERMANY'S HOECHST, BAYER PROFITS DOWN

16 March 1992

STOCK MARKET COMMENTARY: EUROPE

16 March 1992

NORTH AMERICA'S OTC COUGH COLD MARKET

9 March 1992

FISONS' US DIFFICULTIES BRING PROFIT DOWN 17%

9 March 1992

BAYER AG'S JONATHAN TALBUTT

9 March 1992

UPSA DEAL TO SELL TO THE UKRAINE

10 February 1992

OTC PRODUCTS IN EIRE

10 February 1992

STOCK MARKET COMMENTARY: EUROPE

10 February 1992

ALZHEIMER'S DISEASE: A GROWING BURDEN

20 January 1992

US Rx DRUG PRICES ROSE 7.2% IN 1991

20 January 1992

ALZA PRODUCT PROMOTIONS

20 January 1992

ANALGESICS IN THE USA -- AN OPEN DOOR FOR P&G?

6 January 1992

Bayer Austria chief appointed to Pharmig board